Home | Sitemap | Search | ContactA- A A+
   
 
    Public Member Support us  
 

IBCSG 16-98 / BIG 2-97 

Exemestane vs. tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer who have received adjuvant tamoxifen for 2-3 years

DESIGN

Design Trial 16-98

Results & Publications


Presentations


Posters


Publications

Study Chairs
Dr. Hervé Bonnefoi - Genève, Switzerland
Prof. Alan Coates - Centennial Park, Australia

Trial Coordinators
Holly Shaw

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 833 3990
Email: ibcsg16@fstrf.org

Date of Activation
May 1998

Date of Closure
August 31, 2001

Targeted Accrual
4400 patients

Final Accrual
4742 patients


Results Publications Results & Publications


News

07.07.2016:
PINK GOLF TOUR 2016 Golf  Kyburg 25.5.2016 / Golf Gams 30.5.2016 / Golf Winterberg 7.7.2016 

22.06.2016:
Benefiz-Gala mit Spitzenkoch Anton Mosimann Freitag 30. September 2016 im Park Hyatt

08.06.2016:
RACE FOR LIFE - mit Power gegen Krebs am 11. September 2016 auf dem Bundesplatz in Bern

All News

 
  Print